Covered recipient · General Payments record
JENNIFER LINGERFELT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$486.61
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.97 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $137.52 | 2 |
| Lilly USA, LLC | $78.27 | 5 |
| Novo Nordisk AS | $65.78 | 4 |
| ABBVIE INC. | $42.08 | 2 |
| Abbott Laboratories | $20.32 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.08 | 1 |
| Exact Sciences Corporation | $13.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.32 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124811261 | CMS |
| ABBVIE INC. | $18.41 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107542397 | CMS |
| ABBVIE INC. | $23.67 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107542399 | CMS |
| AstraZeneca Pharmaceuticals LP | $123.42 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105748021 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.10 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104242423 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.08 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117849669 | CMS |
| Exact Sciences Corporation | $13.92 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114759118 | CMS |
| Lilly USA, LLC | $14.14 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135643730 | CMS |
| Lilly USA, LLC | $15.26 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135696994 | CMS |
| Lilly USA, LLC | $16.32 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135696392 | CMS |
| Lilly USA, LLC | $16.31 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135700056 | CMS |
| Lilly USA, LLC | $16.24 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135700058 | CMS |
| Novo Nordisk Inc | $13.10 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100337711 | CMS |
| Novo Nordisk Inc | $15.06 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100304967 | CMS |
| Novo Nordisk Inc | $17.62 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100246569 | CMS |
| Novo Nordisk Inc | $20.00 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100435637 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.